News Releases

iuvo BioScience to Exhibit at MedTech 2019, October 22-23

October 15, 2019 – iuvo BioScience will be exhibiting at MedTech 2019 in Rochester, NY on October 22 & 23. Please reach out to us if you would like to schedule a meeting or stop by our booth. For more information on MedTech, or to register for the meeting, check their website here. We hope to see you […]

iuvo BioScience Nominated for MEDTECH2019 Achievement Award

September 19, 2019 – Rush, New York – iuvo BioScience was recently nominated for one of the MEDTECH2019 Achievement Awards, to be presented at the MedTech 2019 annual meeting on October 22, 2019 at the Hyatt Regency in Rochester, New York. iuvo was nominated for the Bio/Med Catalyst award, which is given to an organization […]

Oculos Partner Ocuphire Pharma Announces Completion of the First of Two Phase 2b Clinical Trials

RUSH, NY – September 5, 2019 – Ocuphire Pharma, Inc., a clinical-stage pharmaceutical company and partner of iuvo BioScience’s ophthalmic-focused Oculos Division, announced that it has successfully enrolled 39 glaucoma patients in ORION-1 at 5 U.S. sites from late May to August 2019.  Ocuphire has been collaborating closely with Oculos Development Services to achieve these clinical […]

iuvo BioScience to Attend BIOMEDevice, May 15-16

May 14, 2019 – iuvo BioScience will be attending the BIOMEDevice Expo at the Boston Convention & Exhibition Cente on May 15 and 16. iuvo will not have a booth, but we will be in attendance, and please reach out to us if you’d like to set up a meeting!  iuvo will be represented by John Lanzafame, […]

iuvo BioScience Hires Joe Grappin as Manager, Business Development

RUSH, NY – May 14, 2019 – iuvo BioScience is pleased to announce the addition of Joe Grappin as Manager, Business Development, expanding their commercial footprint for Medical Device Testing services. “We’re very pleased to have Mr. Grappin join the iuvo family, and bring his tremendous experience in technical and business development roles to our […]

Oculos and Optceutics Partner to Bring Expanded Services to Ophthalmic Innovators

Combined expertise and experience broadens the services offered by both companies to clients in a seamless manner – from Concept to Commercialization APRIL 26, 2019 – Rush, New York and London, UK – Oculos (, an industry-leading vertically-integrated ophthalmic R&D organization, and Optceutics (, a leading expert in ophthalmic R&D and the developer of the […]

Genetic Toxicologist Raymond Proudlock Joins iuvo BioScience Extended Team

April 15, 2019 – Rochester, NY – iuvo BioScience is proud to introduce Ray Proudlock as a member of our iuvo BioScience extended team.  Ray will oversee iuvo BioScience’s Genetic Toxicology laboratory.  He is a world-renowned scientist and brings a deep scientific expertise in genetic toxicology and a wealth of experience from leadership roles in […]

iuvo Attending ARVO 2019, April 28 – May 2

March 25, 2019 – iuvo BioScience and Oculos will be attending the ARVO (The Association for Research in Vision and Ophthalmology) 2019 Annual Meeting in Vancouver, British Columbia, Canada from April 28 through May 2 at the Vancouver Convention Centre. Both the preclinical and clinical research teams will be represented at the meeting, and we’d be […]

iuvo Attending SOT ToxExpo, March 10-14, 2019

March 4, 2019 – iuvo BioScience will be attending the 58th Annual Meeting and ToxExpo for the Society of Toxicology, March 10-14, 2019. The meeting will be held at the Baltimore Convention Center at 1 West Pratt Street, Baltimore, Maryland.  To register for the meeting, visit the SOT website here. iuvo will be represented by […]

iuvo BioScience and Oculos Clinical Research Announce Key Hires

September 18, 2018 – Rochester, NY and Tampa, FL – iuvo BioScience is proud to announce, in support of the continued growth of the business, the following professionals joining the organization. Ronil Patel – Business Development Executive Ronil has joined the Oculos Clinical Research team as a Business Development Executive.  Ronil brings over a decade […]